Animas Insulin Pump Attorney
 

If you or a loved one has suffered an adverse cardiac event, heart attack, stroke, or cardiac death while taking Spiriva or Atrovent for the treatment of COPD, or have other questions about potential Spiriva lawsuit, contact the Spiriva Attorneys of Ennis & Ennis, P.A. today for a free confidential case evaluation.

Spiriva News
Free Case Evaluation

Inhaler Drugs Increase Risk of Heart Attacks, Death

-NaturalNews

01/22/2009- People taking inhaled drugs to treat a widespread lung condition may be at increased risk of heart attack and death, according to a Veterans Affairs study conducted by researchers from Wake Forest University and published in the Journal of the American Medical Association.

The researchers analyzed the results of 17 different studies on the risks of inhaled drugs for chronic obstructive pulmonary disease (COPD). COPD involves excess mucus and thickened, narrowed airways, combining the symptoms of emphysema and chronic bronchitis. According to Aaron Milstone of Vanderbilt University Medical School, this leads patients to feel as if they are "living the entire day under water, unable to come to the surface."

COPD affects 24 million people in the United States and kills more than 100,000, making it the country's fourth leading killer.

The researchers found that patients who were taking inhaler drugs to treat COPD had a 1.8 percent chance of developing heart disease, in contrast with only 1.2 percent of COPD patients who had been given other drugs or placebos. This would translate into one extra death for every 40 patients who used the inhalers for one year, the researchers said.

The drugs in question are ipratropium (marketed by Boehringer Ingelheim Pharmaceuticals as Atrovent) and tiotropium (jointly marketed by Boehringer and Pfizer as Spiriva Handihaler).

Earlier this year, Boehringer and Pfizer told the FDA that their product might increase the risk of stroke, but they later retracted that claim, saying it was based on an improper analysis of data.

Because other drugs for the treatment of COPD also have potentially serious side effects, the study authors stopped short of recommending that patients discontinue the use of inhaled medications. Instead, they recommended that patients attempt to improve their cardiovascular health before beginning the drugs, through measures such as quitting smoking, using oxygen and controlling cholesterol and blood pressure.

 

 

 

Click Here To Visit Our Blog Page
Required fields in yellow
 
Name:
Email:
 
Telephone: (123-123-1234)
 
Mailing Address:
 
City:
 
State:
 
Zip Code:
On whose behalf are you inquiring?
Is the person deceased?
Yes No
If the person is deceased please list the cause of death as listed on the death certificate:
 
Please list the date you began and ended using Spiriva:
to
 
Please list the dosage that was used as well as how many times daily it was taken:
 
Please list any side effects of Spiriva that have been experienced:
 
When did you seek medical attention for the side effects you listed above?
 
Please list any additional information you feel may be relevant to your potential Spiriva case:
 
How did you hear about us?
 
 
 

 

 
Nationwide Free Case Evaluations: 1-800-856-6405